Jun. 5 at 9:39 PM
$CNTX @j0hndee1 What an immature response. Why not try to come up with a reasonable rebuttal to @SpencerF post? Furthermore, his summary of what typically happens to beat down biotechs with pending R/S is pretty accurate - down a lot on the news then another 50% drift down after the split.
$CNTX investment in seemingly dying
$BCAB is not looking very good either.
